XSTOPTRK
Market cap12mUSD
Dec 20, Last price
8.52SEK
1D
-0.70%
1Q
-24.60%
IPO
-82.07%
Name
Physitrack PLC
Chart & Performance
P/E
3.76
P/S
0.79
EPS
0.20
Div Yield, %
0.00%
Shrs. gr., 5y
7.68%
Rev. gr., 5y
77.68%
Revenues
15m
+21.31%
Net income
3m
+3,371.47%
CFO
3m
+82.43%
Profile
Physitrack PLC, together with its subsidiaries, operates as a digital healthcare provider worldwide. It offers SaaS platform, a cloud-based software platform used by single practitioners and large healthcare organizations, which enables the digitalization of the patient journey, from initial contact to patient interactions and outcomes tracking. The company also delivers virtual care in three distinct but related patient and insurance plan member need areas, such as prevention and wellness care, acute and chronic care, and surgical care. It offers its virtual care solutions to healthcare companies, including private and public hospitals, clinics, and other business owners. The company was formerly known as Physitrack Limited and changed its name to Physitrack PLC in May 2021. Physitrack PLC was incorporated in 2012 and is based in London, the United Kingdom.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑11 | 2019‑11 | 2018‑11 | 2017‑11 | 2016‑11 | 2015‑11 | |
| Income | |||||||||
Revenues | 15,177 21.31% | 12,510 60.10% | 7,814 34.09% | ||||||
Cost of revenue | 11,311 | 12,546 | 5,364 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | 3,866 | (35) | 2,450 | ||||||
NOPBT Margin | 25.47% | 31.35% | |||||||
Operating Taxes | (114) | (41) | 175 | ||||||
Tax Rate | 7.12% | ||||||||
NOPAT | 3,980 | 6 | 2,275 | ||||||
Net income | 3,205 3,371.47% | 92 -111.33% | (815) -218.39% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 1 | ||||||||
Long-term debt | 3,578 | 832 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | 3,740 | 9,701 | |||||||
Net debt | 2,964 | 175 | (13,402) | ||||||
| Cash flow | |||||||||
Cash from operating activities | 2,648 | 1,452 | 660 | ||||||
CAPEX | (25) | (4,496) | (6) | ||||||
Cash from investing activities | (5,036) | (14,785) | (4,544) | ||||||
Cash from financing activities | 2,342 | 796 | 14,850 | ||||||
FCF | 3,296 | 1,121 | 653 | ||||||
| Balance | |||||||||
Cash | 536 | 578 | 13,325 | ||||||
Long term investments | 79 | 79 | 79 | ||||||
Excess cash | 31 | 13,012 | |||||||
Stockholders' equity | 1,671 | (1,534) | (1,627) | ||||||
Invested Capital | 32,891 | 34,276 | 24,918 | ||||||
ROIC | 11.85% | 0.02% | 13.49% | ||||||
ROCE | 11.75% | 8.55% | |||||||
| EV | |||||||||
Common stock shares outstanding | 16,261 | 16,261 | 13,689 | ||||||
Price | 16.20 -32.36% | 23.95 -58.85% | 58.20 | ||||||
Market cap | 263,424 -32.36% | 389,445 -51.12% | 796,728 | ||||||
EV | 266,388 | 390,652 | 783,326 | ||||||
EBITDA | 7,486 | 2,399 | 2,485 | ||||||
EV/EBITDA | 35.58 | 162.86 | 315.27 | ||||||
Interest | 375 | 87 | |||||||
Interest/NOPBT | 9.70% | ||||||||